O-1918
Manufacturing · United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.azd8330.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About O-1918
AZD8330 is a MEK1/2 inhibitor designed for the treatment of gynecologic malignancies. The product targets specific pathways involved in cancer progression, aiming to provide effective therapeutic options for patients. It is intended for use in clinical settings, particularly for individuals diagnosed with gynecological cancers. The company focuses on advancing cancer treatment through innovative pharmacological solutions.Explore more
Popular SearchesO-1918EhCPADHSIC Code 28,283NAICS Code 32,325Show more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is O-1918 your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
O-1918, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at O-1918
Check out if O-1918 is spiking on competitors!
Product Launch: Get notified when O-1918 launches new products
Funding: Get notified immidiatlly once O-1918 has new funding data
Check if O-1918 has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on O-1918 recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Click to see if O-1918 had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at O-1918
Find more new buyers
Compare Similar Companies to O-1918
Compare insights from companies similar to O-1918, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
O-1918
<$5M
11-50
Private
-
-
N/A
Company Profile Activity
Activity Insights
O-1918 is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
O-1918 is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about O-1918.
O-1918 Tech Stack
A closer look at the technologies used by O-1918
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding O-1918
Sign Up For FreeTo access detailed company insights
AZD8330 is a MEK1/2 inhibitor designed for the treatment of gynecologic malignancies. The product targets specific pathways involved in cancer progression, aiming to provide effective therapeutic options for patients. It is intended for use in clinical settings, particularly for individuals diagnosed with gynecological cancers. The company focuses... Read More
